Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease

Published:2012-02 Issue:1 Volume:6 Page:108-111
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Steenholdt Casper,Svenson Morten,Bendtzen Klaus,Thomsen Ole Østergaard,Brynskov Jørn,Ainsworth Mark Andrew

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/6/1/108/7093790/6-1-108.pdf

Reference20 articles.

1. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease;Miehsler;J Crohns Colitis,2010

2. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006;Clark;Gastroenterology,2007

3. Adverse effects of biologics used for treating IBD;Stallmach;Best Pract Res Clin Gastroenterol,2010

4. Serum sickness, encephalitis and other complications of anti-cytokine therapy;Vermeire;Best Pract Res Clin Gastroenterol,2009

5. Acute infusion reactions induced by monoclonal antibody therapy;Maggi;Expert Rev Clin Immunol,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Oncoimmunology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome;Life;2024-03-18

2. Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative;Scandinavian Journal of Gastroenterology;2024-02-14

3. Anaphylactic Responses to Neuromuscular Blockade Drugs and Reversal Drugs;Current Anesthesiology Reports;2023-09-09

4. Mast Cells and Basophils in IgE-Independent Anaphylaxis;International Journal of Molecular Sciences;2023-08-15

5. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature;World Journal of Cardiology;2023-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3